Kymera Therapeutics, Inc.
US ˙ NasdaqGM ˙ US5015751044

SecurityKYMR / Kymera Therapeutics, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership361,772 shares
Latest Disclosed Value $ 30,131,989
Franklin Resources Inc reports 2.03% increase in ownership of KYMR / Kymera Therapeutics, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 361,772 shares of Kymera Therapeutics, Inc. (US:KYMR) valued at $30,131,990 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 354,575 shares of Kymera Therapeutics, Inc.. This represents a change in shares of 2.03% during the quarter. The current value of the position is $26,485,328 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F KYMERA THERAPEUTICS COM 501575104 361,772 7,197 2.03 30,132 9.21 0.0012
2026-02-11 2025-12-31 13F KYMERA THERAPEUTICS COM 501575104 354,575 322,913 1,019.88 27,589 1,439.56 0.0068
2025-11-13 2025-09-30 13F KYMERA THERAPEUTICS COM 501575104 31,662 -1,987 -5.91 1,792 22.07 0.0004
2025-08-12 2025-06-30 13F KYMERA THERAPEUTICS COM 501575104 33,649 822 2.50 1,468 63.47 0.0004
2025-05-13 2025-03-31 13F KYMERA THERAPEUTICS COM 501575104 32,827 -5,540 -14.44 898 -41.80 0.0003
2025-02-12 2024-12-31 13F KYMERA THERAPEUTICS COM 501575104 38,367 8,927 30.32 1,544 13.87 0.0004
2024-11-27 2024-09-30 13F/A-1 KYMERA THERAPEUTICS COM 501575104 29,440 7,647 35.09 1,356 108.46 0.0004
2024-11-12 2024-09-30 13F KYMERA THERAPEUTICS COM 501575104 29,440 7,647 1,356 0.0001
2024-08-14 2024-06-30 13F KYMERA THERAPEUTICS COM 501575104 21,793 21,793 651 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.